We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
14 hedge funds and large institutions have $1.18M invested in Atossa Therapeutics in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
71% more capital invested
Capital invested by funds: $688K → $1.18M (+$488K)
1.24% more ownership
Funds ownership: 0.03% → 1.27% (+1.2%)
26% less funds holding
Funds holding: 19 → 14 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
14
Holders Change
-5
Holders Change %
-26.32%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.22M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$390K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.39K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.92K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$80K |
| 2 |
Barclays
London,
United Kingdom
|
-$72K |
| 3 |
VF
Virtu Financial
New York
|
-$39K |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$26K |
| 5 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$16K |
